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These findings raise many important
new questions. For example, was the
observed lifespan extension in mice
caused by delaying deaths from cancer,
delaying the mechanisms of aging, or
both? Does mTOR inhibition decrease
stem cell senescence or increase the
function of various tissue stem cell popu-
lations in comparison with age-matched
controls? Perhaps most importantly,
what are the molecular mechanisms con-
necting mTOR and aging? Potential clues
to this question come from our under-
standing of mTOR biology. The mTOR
kinase nucleates two distinct signaling
complexes, mTORC1 and mTORC2, one
of which (mTORC1) is allosterically in-
hibited by rapamycin. The activation of
mTORC1 in response to a broad range of
progrowth signals is known to regulate
mitochondrial activity, which itself has
been shown in several studies to be
involved in the regulation of lifespan.Mito-
chondria may exert this influence through
the generation of intracellular reactive
oxygen species (ROS) (Schieke and Fin-
kel, 2006), which, in previous work, have
been suggested to contribute to HSC
exhaustion (Tothova et al., 2007). The
connection between mTOR and ROS
production is far from understood at the
molecular level, but these typesof findings
point to a potential direction for future
research into the role of mTOR signaling
in aging and stem cell function.
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Instructive and permissive models of commitment have been proposed for hematopoietic cytokines. In
recent issues of Science and Cell, Rieger et al. (2009) and Sarrazin et al. (2009) together show that cytokines
can instruct lineage choice.Multipotent hematopoietic stem cells
(HSCs) with the ability to reconstitute the
blood and lymphoid lineages long term
and to self-renew are predominantly
quiescent, dividing only in response to
demand for blood cells (Wilson et al.,
2008). Both multilineage and lineage-
specific cytokines synergistically regulate
the proliferation and differentiation of
these long term (LT)-HSCs that express
receptors for several of the lineage-
specific cytokines. A major area of
conjecture in the HSC field has been
whether cytokines can ‘‘instruct’’ lineage
commitment (Metcalf, 1998) or whether
their actions are simply ‘‘permissive’’234 Cell Stem Cell 5, September 4, 2009 ª2(Enver et al., 1998), allowing the survival
and expansion of already committed
cells. Although both cell-autonomous
transcription factors (Laiosa et al., 2006)
and the activation of ectopically ex-
pressed cytokine receptors (Kondo et al.,
2000) have been shown to instruct lineage
choice, it has been technically difficult to
demonstrate an instructive action of cyto-
kines in nonengineered cells. Two recent
papers that used novel approaches
(Rieger et al., 2009; Sarrazin et al., 2009)
convincingly demonstrate that cytokines
can instruct.
Macrophage CSF (M-CSF), also known
as colony stimulating factor-1 (CSF-1)009 Elsevier Inc.and granulocyte CSF (G-CSF), generate
clones from cultured hematopoietic cells
that are composed almost exclusively
of macrophages (Ms) or granulocytes
(Gs), respectively. Using novel bioimaging
approaches that permit continuous long-
term observation at the single-cell level
(Eilken et al., 2009), Rieger et al. (2009)
used time-lapse movies of cultures of
purified bipotent granulocyte/monocyte
progenitors (GMPs) to follow the fate of
unselected progenitors as they differen-
tiate to either Ms or Gs. GMPs, which do
not express lysozyme, were obtained
from Lys::GFP mice in which enhanced
green fluorescent protein expression is
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Previewsdriven from the lysozymeM
gene locus. Thus, upon initial
commitment to either the M
or G lineage, the differenti-
ating GMPs could be de-
tected on the basis of the
onset of GFP expression.
Ms, which are adherent,
spindle shaped, and F4/80+,
were easily distinguished
from Gs, which smaller, non-
adherent, and Ly6G+. After
short-term culture of GMPs
in G-CSF or CSF-1, they
were switched to medium
containing other cytokines
that maintained the cells.
Importantly, this system
allows visualization of cell
death and unilineage commit-
ment of all GMPs in the field.
After culture of GMPs and
their progeny in G-CSF or
CSF-1 for 2 days, almost
all the resulting pedigrees
were pure Gs or pure Ms, re-
spectively, and cell death
occurred in less than 13% of
these pedigrees. In the
absence of cell death, colo-
nies could have resulted
from ‘‘instructed’’ differentia-
tion of bipotent GMPs or
by ‘‘permissive’’ expansion
of any unilineage-restricted
cells that contaminated the
pre-existing GMP pool. How-
ever, the maximum percent-
ages of potentially unilineage-
restricted cells in the GMP population,
simultaneously determined by scoring
colonies that arose in cultures with
a mixture of multilineage cytokines, were
much lower than the high percentage of
unilineage colonies induced by CSF-1 or
G-CSF. Furthermore, other experiments
indicated that 90% of the GMPs in the
starting population were bipotent. Thus,
the authors have clearly demonstrated
that CSF-1 and G-CSF can instruct most
GMPs into a specific lineage.
Focusing on a different multipotent cell,
the HSC, and the role of a transcription
factor, which they show regulates respon-
siveness to CSF-1, Sarrazin et al. (2009)
independently conclude that cytokines
can instruct progenitor fates. Highly ex-
pressed in maturemonocytes andmacro-
phages, MafB is a bZip-type transcription
factor that decreases proliferation and
accelerates macrophage differentiation
when ectopically expressed in committed
myeloid progenitors (Kelly et al., 2000).
Comparing LT-HSC-enriched popula-
tions from WT and MafB/ mice, the
authors showed that the primitive
MafB/ cells exhibited higher prolifera-
tion rates than WT cells. Furthermore,
in a competitive reconstitution assay,
MafB/ HSCs competed better than
WT HSCs, resulting in an increased
contribution of the MafB/ cells to the
HSC fraction. However, the competitive
advantage of the MafB/ HSCs was not
observed in the lymphoid or erythroid
lineages. Rather, it was restricted to a
myeloid-specific repopulation. Interest-
ingly, despite this myeloid-based repopu-
lation advantage, there was no increase in
the size of the myeloid cell
compartment. Furthermore,
after serial transplantation,
MafB/ HSCs did not differ
from WT HSCs, either in their
self-renewal capacity or their
ability to contribute nonmye-
loid lineages, but did maintain
a progressively increasing
myeloid repopulation advan-
tage on serial transfer in irra-
diated hosts. In vitro experi-
ments demonstrated that
MafB/ HSCs had the
intrinsic capacity to generate
more myeloid progeny than
WT HSC and that MafB se-
lectively attenuates CSF-1R
signaling. Additional trans-
plantation experiments with
fetal liver cells in which the
CSF-1R was knocked down
showed that MafB/ HSCs
are specifically sensitized to
CSF-1-driven myeloid repo-
pulation in vivo.
Concentrating on the effect
of MafB on CSF-1-regulated
differentiation, Sarrazin et al.
next showed that loss of
MafB enhanced CSF-1-
driven commitment to the
myeloid lineage. The tran-
scription factor PU.1 is
a myeloid master regulator
that is both necessary and
sufficient to drive myeloid
fate (Iwasaki and Akashi,
2007), and its increased
expression is an important early step in
myeloid differentiation. Thus, to detect
myeloid commitment, Sarrazin et al.
used purified HSCs from PU.1-GFP
reporter mice. Incubation of these cells
with CSF-1 for only 16 hr increased PU.1
expression significantly in wild-type cells
and dramatically in MafB/ cells, indi-
cating that MafB attenuates CSF-1-
induced activation of PU.1. Interestingly,
MafB was highly expressed in LT-HSC-
enriched populations and in the PU.1
HSC-enriched fraction, but not in the
downstream PU.1+ multipotent progen-
itor (MPP) or committed myeloid progen-
itor fractions. This observation, together
with the increased PU.1 expression of
MafB-deficient HSCs compared with WT
HSCs after short-term incubation with
CSF-1, suggested that MPP development
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Figure 1. Cytokines Instruct Lineage Commitment
(A) Approximately 90% of purified granulocyte-monocyte progenitors (GMPs)
differentiate to pure granulocyte (G) colonies with G-CSF or pure macrophage
(M) colonies with CSF-1.
(B) The transcription factor MafB selectively limits CSF-1-instructed myeloid
commitment in hematopoietic stem cells. In populations enriched for long-
term repopulating hematopoietic stem cells (LT-HSC), CSF-1-induced expres-
sion of the myeloid transcription factor PU.1 is repressed. Decreased expres-
sion of MafB in multipotent progenitors (MPPs) leads to increased PU.1
expression and their subsequent differentiation into the myeloid lineage. Not
shown is that MafB deficiency in LT-HSC specifically increases asymmetric
cell divisions, in which one daughter cell is PU.1+ and the other PU.1, thereby
maintaining stem cell numbers for differentiation to nonmyeloid lineages.Cell Stem Cell 5, September 4, 2009 ª2009 Elsevier Inc. 235
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PreviewsrequiresMafB downregulation. To directly
examine CSF-1-induced commitment
and its regulation by MafB, the authors
cultured single cells of the PU.1 HSC-
enriched fraction of PU.1-GFP reporter
mice until their first division. By following
GFP expression, they observed prolifera-
tive, differentiative, and asymmetric
divisions, but found that MafB deficiency,
consistent with its failure to affect
self-renewal or commitment to other
lineages, specifically enhanced CSF-1-
driven asymmetric myeloid commitment
divisions.
The studies of Sarrazin et al., with their
focus on MafB, do not as directly address
the question of whether CSF-1 induces
commitment as those of Riegler et al.
However, their results indicate an instruc-
tive role revealed by MafB deficiency and
provide us with a fascinating paradigm
for cytokine/transcription factor interac-
tions. Together, these studies demon-
strate the direct effect of cytokines on
lineage choice in nonengineered cells
and how transcription factor expression
can limit this instructive cytokine effect
(Figure 1). The results set the scene for236 Cell Stem Cell 5, September 4, 2009 ª2future investigations. The novel imaging
technology will be useful in determining
which receptor-based signaling pathways
are responsible for commitment. Other
important questions are: How do tran-
scription factors, such as MafB, attenuate
cytokine signaling? Are the factors down-
regulating MafB synthesis cell intrinsic
(stochastic events or epigenetic changes),
or are external cues involved? As far as
CSF-1 receptor signaling is concerned,
are the three functionally distinct CSF-1
isoforms (Pixley and Stanley, 2004) and
the novel CSF-1 receptor ligand, inter-
leukin-34, involved in differential regula-
tion in the stem cell niche? Finally, in
viewof the interesting interaction between
MafB and CSF-1 receptor signaling and
the deterministic effect of CSF-1, it will
be of interest to determine how CSF-1
receptor deficiency affects HSC self-
renewal and differentiation in vivo.
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